Cost-effectiveness of community-based integrated care model for patients with diabetes and depressive symptoms

Abstract The coexistence of type 2 diabetes (T2DM) and depression is a prominent example of multimorbidity. In previous work, we reported the results of a completed cluster-randomized controlled trial that was conducted in eight community health centers in China. We enrolled adults (≥18 years) with...

Full description

Saved in:
Bibliographic Details
Main Authors: Yanshang Wang, Dan Guo, Yiqi Xia, Mingzheng Hu, Ming Wang, Zhenyu Shi, Xiaolong Guan, Dawei Zhu, Ping He
Format: Article
Language:English
Published: Nature Portfolio 2025-03-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-025-58120-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849699516075212800
author Yanshang Wang
Dan Guo
Yiqi Xia
Mingzheng Hu
Ming Wang
Zhenyu Shi
Xiaolong Guan
Dawei Zhu
Ping He
author_facet Yanshang Wang
Dan Guo
Yiqi Xia
Mingzheng Hu
Ming Wang
Zhenyu Shi
Xiaolong Guan
Dawei Zhu
Ping He
author_sort Yanshang Wang
collection DOAJ
description Abstract The coexistence of type 2 diabetes (T2DM) and depression is a prominent example of multimorbidity. In previous work, we reported the results of a completed cluster-randomized controlled trial that was conducted in eight community health centers in China. We enrolled adults (≥18 years) with type 2 diabetes and depressive symptoms. In the intervention group, a comprehensive care plan was developed based on the Integrated Care Model for Patients with Diabetes and Depression (CIC-PDD). In this study, we explore the cost-effectiveness of the CIC-PDD by conducting a one-year within-trial economic evaluation from the health system, multipayer and societal perspectives. Health outcomes are quality-adjusted life years (QALYs) and depression-free days (DFDs), and we calculate incremental cost-effectiveness ratios (ICERs) and cost-effectiveness probability. Among 630 participants (275 intervention, 355 usual care), the cost per QALY gained is $7,922.82, $7,823.85, and $7,409.46, with cost-effectiveness probabilities of 66.41%- 94.45%. The cost per DFD is $2.63–$2.82, requiring a willingness-to-pay of $9.00–$10.50 for >95% probability of cost-effectiveness. We find that the CIC-PDD model demonstrates cost-effectiveness within primary health care settings, but further studies are needed to assess its long-term sustainability and scalability. Trial registration: 35 ChiCTR2200065608.
format Article
id doaj-art-47342d8ec76f4eecad1631df0433c3fc
institution DOAJ
issn 2041-1723
language English
publishDate 2025-03-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj-art-47342d8ec76f4eecad1631df0433c3fc2025-08-20T03:18:34ZengNature PortfolioNature Communications2041-17232025-03-0116111010.1038/s41467-025-58120-xCost-effectiveness of community-based integrated care model for patients with diabetes and depressive symptomsYanshang Wang0Dan Guo1Yiqi Xia2Mingzheng Hu3Ming Wang4Zhenyu Shi5Xiaolong Guan6Dawei Zhu7Ping He8School of Public Health, Peking UniversityDepartment of Research and Teaching, China Aerospace Science & Industry Corporation 731 HospitalSchool of Public Health, Peking UniversitySchool of Public Health, Peking UniversitySchool of Public Health, Peking UniversitySchool of Public Health, Peking UniversitySchool of Public Health, Peking UniversitySchool of Pharmaceutical Sciences, Peking UniversityChina Center for Health Development Studies, Peking UniversityAbstract The coexistence of type 2 diabetes (T2DM) and depression is a prominent example of multimorbidity. In previous work, we reported the results of a completed cluster-randomized controlled trial that was conducted in eight community health centers in China. We enrolled adults (≥18 years) with type 2 diabetes and depressive symptoms. In the intervention group, a comprehensive care plan was developed based on the Integrated Care Model for Patients with Diabetes and Depression (CIC-PDD). In this study, we explore the cost-effectiveness of the CIC-PDD by conducting a one-year within-trial economic evaluation from the health system, multipayer and societal perspectives. Health outcomes are quality-adjusted life years (QALYs) and depression-free days (DFDs), and we calculate incremental cost-effectiveness ratios (ICERs) and cost-effectiveness probability. Among 630 participants (275 intervention, 355 usual care), the cost per QALY gained is $7,922.82, $7,823.85, and $7,409.46, with cost-effectiveness probabilities of 66.41%- 94.45%. The cost per DFD is $2.63–$2.82, requiring a willingness-to-pay of $9.00–$10.50 for >95% probability of cost-effectiveness. We find that the CIC-PDD model demonstrates cost-effectiveness within primary health care settings, but further studies are needed to assess its long-term sustainability and scalability. Trial registration: 35 ChiCTR2200065608.https://doi.org/10.1038/s41467-025-58120-x
spellingShingle Yanshang Wang
Dan Guo
Yiqi Xia
Mingzheng Hu
Ming Wang
Zhenyu Shi
Xiaolong Guan
Dawei Zhu
Ping He
Cost-effectiveness of community-based integrated care model for patients with diabetes and depressive symptoms
Nature Communications
title Cost-effectiveness of community-based integrated care model for patients with diabetes and depressive symptoms
title_full Cost-effectiveness of community-based integrated care model for patients with diabetes and depressive symptoms
title_fullStr Cost-effectiveness of community-based integrated care model for patients with diabetes and depressive symptoms
title_full_unstemmed Cost-effectiveness of community-based integrated care model for patients with diabetes and depressive symptoms
title_short Cost-effectiveness of community-based integrated care model for patients with diabetes and depressive symptoms
title_sort cost effectiveness of community based integrated care model for patients with diabetes and depressive symptoms
url https://doi.org/10.1038/s41467-025-58120-x
work_keys_str_mv AT yanshangwang costeffectivenessofcommunitybasedintegratedcaremodelforpatientswithdiabetesanddepressivesymptoms
AT danguo costeffectivenessofcommunitybasedintegratedcaremodelforpatientswithdiabetesanddepressivesymptoms
AT yiqixia costeffectivenessofcommunitybasedintegratedcaremodelforpatientswithdiabetesanddepressivesymptoms
AT mingzhenghu costeffectivenessofcommunitybasedintegratedcaremodelforpatientswithdiabetesanddepressivesymptoms
AT mingwang costeffectivenessofcommunitybasedintegratedcaremodelforpatientswithdiabetesanddepressivesymptoms
AT zhenyushi costeffectivenessofcommunitybasedintegratedcaremodelforpatientswithdiabetesanddepressivesymptoms
AT xiaolongguan costeffectivenessofcommunitybasedintegratedcaremodelforpatientswithdiabetesanddepressivesymptoms
AT daweizhu costeffectivenessofcommunitybasedintegratedcaremodelforpatientswithdiabetesanddepressivesymptoms
AT pinghe costeffectivenessofcommunitybasedintegratedcaremodelforpatientswithdiabetesanddepressivesymptoms